A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

NCT04982276 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma

Interventions

BIOLOGICAL: AK109
DRUG: paclitaxel
DRUG: paclitaxel
BIOLOGICAL: AK104

Sponsor

Akeso